Status:
COMPLETED
ONO-7746 Study in Healthy Adult Subjects
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Healthy Adult Subjects
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The primary objective of this study is to evaluate the safety and tolerability of ONO-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynam...
Eligibility Criteria
Inclusion
- Healthy non-smoking male or female subjects (18-55 years inclusive)
- Body mass index (BMI) of 19-35 kg/m² (inclusive)
- For females: postmenopausal, non-lactating and non-pregnant
Exclusion
- History or presence of clinically significant disease
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00956371
Start Date
August 1 2009
Last Update
June 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Austin
Austin, Texas, United States, 78744